Packaging and Containers

Packaging Materials Impact on Pharmaceutical Stability Testing

Posted on By

Pharmaceutical packaging materials serve more than a containment role—they are active participants in preserving drug quality, safety, and efficacy. From shielding against moisture, oxygen, and light to ensuring physical protection, packaging materials must be carefully selected and validated to maintain product stability under ICH-recommended conditions. As Stability Studies simulate storage over time, the packaging’s performance becomes a critical determinant of shelf life and regulatory acceptance.
Click to read the full article.

Packaging and Containers, Packaging Materials Impact on Stability Testing

Pharmaceutical Packaging and Containers: GMP Role in Stability and Shelf Life

Posted on By

Pharmaceutical packaging is far more than a visual or protective layer—it is a critical component that directly influences product stability, shelf life, regulatory compliance, and patient safety. The choice of packaging and container closure systems must consider compatibility with the drug product, protection against environmental factors, integrity over time, and suitability for the intended storage and distribution conditions.
Click to read the full article.

Packaging and Containers

Pharmaceutical Containers and Closures in Stability Testing

Posted on By

The choice of containers and closures plays a decisive role in the pharmaceutical product lifecycle, especially in determining stability, shelf life, and patient safety. Packaging components such as bottles, vials, caps, stoppers, and liners must not only be inert and protective but also compatible with the drug product across varied environmental conditions. In Stability Studies, where products are stored under accelerated and long-term conditions, the container-closure system must ensure integrity, prevent degradation, and comply with global regulatory expectations.
Click to read the full article.

Packaging and Containers, Pharmaceutical Containers and Closures for Stability

Compatibility of Drug Formulation with Packaging Materials

Posted on By

Packaging systems are more than passive containers—they actively influence the stability, safety, and quality of pharmaceutical drug products. Incompatibility between a formulation and its packaging can result in degradation, loss of potency, or contamination through leachables. Regulatory agencies like the FDA, EMA, and ICH mandate that compatibility be demonstrated through scientifically validated studies. This ensures that no interaction occurs between the formulation and the container-closure system that might compromise safety or efficacy during the product’s shelf life.
Click to read the full article.

Compatibility of Drug Formulation with Packaging, Packaging and Containers

Container Closure Integrity Testing (CCI) in Pharmaceutical Packaging

Posted on By

Container Closure Integrity Testing (CCI) is a critical component of pharmaceutical packaging validation, particularly for sterile and parenteral drug products. It ensures that the container-closure system maintains its integrity throughout the product’s shelf life, thereby preserving sterility, potency, and safety. Regulatory authorities like the FDA, EMA, and WHO emphasize CCI as an essential requirement for GMP compliance and product approval.
Click to read the full article.

Container Closure Integrity Testing, Packaging and Containers

Sustainable Packaging for Drug Stability in Pharmaceuticals

Posted on By

Pharmaceutical companies are increasingly being challenged to reduce their environmental footprint without compromising product quality or regulatory compliance. Packaging, a major contributor to the industry’s carbon emissions and waste, has become a central focus in these sustainability efforts. However, any move toward eco-friendly packaging must still meet stringent stability requirements to ensure product safety and efficacy throughout its shelf life.
Click to read the full article.

Packaging and Containers, Sustainable Packaging for Drug Stability

How to Select the Right Container Closure Systems for Stability Testing

Posted on By

The primary function of a container closure system is to protect the drug product from environmental factors such as moisture, oxygen, light, and microbial contamination. During long-term and accelerated stability studies, inadequate packaging can compromise the product’s chemical and physical properties. That’s why a well-qualified CCS ensures that the drug product remains within specification throughout its intended shelf life.
Click to read the full article.

Packaging and Containers, Pharmaceutical Containers and Closures for Stability

Understanding Material Compatibility in Pharmaceutical Packaging

Posted on By

Pharmaceutical products, especially those with sensitive APIs or excipients, may react with packaging components. These reactions can lead to physical instability, chemical degradation, or contamination. Therefore, understanding the interaction between the drug product and packaging materials is critical when designing a container closure system (CCS) for stability studies.
Click to read the full article.

Packaging and Containers, Pharmaceutical Containers and Closures for Stability